Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes

Annals of Surgical Oncology

Volumn 7, Issue 2, 2000, Pages 139-144

  Volpe, Carmine M ^a,b   Driscoll, Deborah L ^a   Douglass Jr , Harold O ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

D2 gastric resection; Number of resected lymph nodes

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; TREATMENT OUTCOME;

EID: 0034082614     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0139-1     Document Type: Article

References (38)

1. Dahlberg M, Glimelius B, Pahlman L. Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish rectal cancer trial. Ann Surg 1999;229:493-97.
2. Poulin EC, Mamazza J, Schlachta CM, Gregoire R, Roy N. Laparoscopic resection does not adversely affect early survival curves in patients undergoing surgery for colorectal adenocarcinoma. Ann Surg 1999;229:487-92.
3. Cuschieri A, Fayers P, Fielding J, et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 1996;347:995-9.
4. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJH. Extended lymph-node dissection for gastric cancer. N Engl J Med 1999;340:908-14.
5. Japanese Research Society for Gastric Cancer. Treatment results of gastric carcinoma in Japan, 39th report of nation-wide registry in 1979-1982, Kanehana Publishers, Tokyo, 1995.
6. Noguchi Y, Imada T, Matsumoto A., Coit DG, Brennan MF. Radical surgery for gastric cancer: a review of the Japanese experience. Cancer 1989;64:2053-62.
7. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-26.
8. Volpe CM, Koo J, Miloro SM, Driscoll DL, Nava HR, Douglass HO Jr. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma. J Am Coll Surg 1995;181: 56-64.
9. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 1995;76:1302-12.
10. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 1993;80:1015-8.
11. Sue-Ling HM, Johnston D, Martin IG, et al. Gastric cancer: a curable disease in Britain. BMJ 1993;307:591-96.
12. Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind C. UICC Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours. 4th ed. New York: Springer-Verlag, 1997.
13. Bunt AMG, Hermans J, van de Velde CJH, et al. Lymph node retrieval in a randomized trial on western-type versus Japanese-type surgery in gastric cancer. J Clin Oncol 1996;14:2289-94.
14. Bunt AMG, Hogendoorn PCW, van de Velde CJH, Bruijn JA, Hermans J. Lymph node staging standards in gastric cancer. J Clin Oncol 1995;13:2309-16.
15. Kajitani T, Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology: parts I and II. Jpn J Surg 1981;11:127-45.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-86.
17. Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187-220.
18. Brennan MF, Karpeh M. Surgery for gastric cancer: the American view. Semin Oncol 1996;23:352-59.
19. Kern KA. Natural history of surgically treated gastric cancer. In: Sugarbaker PH, ed. Management of Gastric Cancer. Boston: Kluwer Academic, 1991:532-36.
20. Kelsen DP. Adjuvant and neoadjuvant therapy for gastric cancer. Semin Oncol 1996;23:379-89.
21. Wagner PK, Ramaswamy A, Ruschoff J, Schmitz-Moormann P, Rothmund M. Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 1991; 78:825-27.
22. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745-8.
23. Volpe CM, Driscoll DL, Miloro SM, Douglass HO Jr. Survival benefit of extended D2 resection for proximal gastric cancer. J Surg Oncol 1997;64:231-6.
24. Bunt AMG, Hermans J, Smit VTHBM, van de Velde CJH, Fleuren GJ, Bruijn JA. Surgical/pathologic stage migration confounds comparison of gastric cancer survival rates between Japan and western countries. J Clin Oncol 1995;13:19-25.
25. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic technique as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312:1604-8.
26. Nakajima T, Nishi M. Surgery and adjuvant chemotherapy for gastric cancer. Hepatogastroenterology 1989;36:79-85.
27. Wu C, Hsieh M, Lo S, et al. Morbidity and mortality after radical gastrectomy for patients with carcinoma of the stomach. J Am Coll Surg 1995;181:26-32.
28. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K. Pancreas- preserving total gastrectomy for proximal gastric cancer. World J Surg 1995;19:532-36.
29. Degiuli M, Sasako M, Ponti A, Soldati T, Danese F, Calvo F. Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol 1998;16:1490-3.
30. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection: results of the German Gastric Carcinoma Study. Br J Surg 1992; 80:1015-8.
31. Roder JD, Bottcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ. Prognostic factors in gastric carcinoma. Cancer 1993;72:2089-97.
32. Hermanek P, Wittekind C. News of TNM and its classification of gastric cancer. World J Surg 1995;19:491-5.
33. Wu CW, Hsieh MC, Lo SS, Tsay SH, Lui WY, P'eng FK. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut 1996;38:525-27.
34. Lee JS, Douglass HO Jr. D2 dissection for gastric cancer. Surg Oncol 1997;6:215-25.
35. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. 5th ed. New York: John Wiley & Sons, 1997.
36. Kodera Y, Yamamura Y, Shimizu Y, et al. The number of metastatic lymph nodes: a promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. J Am Coll Surg 1998;187:597-603.
37. Kubba AK, Maclntyre IMC. Gastric cancer distal to the cardia: prevention or cure. Surg Oncol 1997;6:111-24.
38. Blot WJ, Devesa-Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of esophagus and gastric cardia. JAMA 1991;265: 1287-9.